India Expands COVID-19 Vaccine Portfolio with New Approvals Including Omicron JN.1 Variant Shot
India’s COVID-19 vaccination landscape continues to evolve, with the Central Drugs Standard Control Organization (CDSCO) releasing an updated list of approved vaccines as of...
Merck Launches Industry-First Bio-Based Solvent Portfolio for (HPLC)
In a significant step toward greener laboratory practices, Merck Group has launched the industry’s first bio-based solvent portfolio designed specifically for high-performance liquid chromatography...
Eli Lilly Expands Oncology Pipeline with Kelonia Buyout, Targets Next-Gen CAR-T Therapy
In a strategic move set to reshape the future of cancer treatment, Eli Lilly and Company has announced its acquisition of Kelonia Therapeutics in...
Novo Nordisk’s Etavopivat Cracks Phase 3 Goals: A Potential New Standard of Care for Sickle Cell Disease
Novo Nordisk’s Etavopivat hits the mark in Pivotal Sickle Cell Study. Etavopivat, an oral, once-daily pyruvate kinase-R (PKR) activator displayed supercilious results showing 27%...
CDSCO Directs Stakeholders to Submit Prior Intimation for BA/BE Studies Online via Sugam Portal
In a significant regulatory development, the Central Drug Standard Control Organization, (CDSCO) has issued a circular mandating stakeholders to submit prior intimation for...
NIPER Mohali Partners with Novartis to Advance Industry–Academia Collaboration
By Dose Daily News Bureau
20th April, 2026
19:00 PM IST
The National Institute of Pharmaceutical Education and Research (NIPER) Mohali, has signed a formal collaboration...
